Page last updated: 2024-09-05

sb 203580 and diosgenin

sb 203580 has been researched along with diosgenin in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(diosgenin)
Trials
(diosgenin)
Recent Studies (post-2010) (diosgenin)
3,48941,1371,0956723

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beneytout, JL; Bertrand, J; Leger, DY; Liagre, B1
Beneytout, JL; Bertrand, J; Léger, DY; Lepage, C; Liagre, B; Martin, F1

Other Studies

2 other study(ies) available for sb 203580 and diosgenin

ArticleYear
Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-kappaB binding.
    International journal of molecular medicine, 2005, Volume: 16, Issue:6

    Topics: Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cyclooxygenase 2; Diosgenin; DNA Fragmentation; Enzyme Activation; Humans; Imidazoles; K562 Cells; MAP Kinase Signaling System; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phytosterols; Poly(ADP-ribose) Polymerases; Pyridines

2005
Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells.
    Cancer letters, 2011, Feb-28, Volume: 301, Issue:2

    Topics: Apoptosis; Blotting, Western; Cyclooxygenase 2; Diosgenin; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; HT29 Cells; Humans; Imidazoles; MAP Kinase Signaling System; Microscopy, Phase-Contrast; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation

2011